English

BioStock: Saniona comments on the possible listing in the USA

Report this content

On November 30, Saniona released its Q3 report and in addition to summing up important advances during the quarter, the report also made it clear that the biotechnology company is considering listing its share on Nasdaq USA. BioStock reached out to CEO Rami Levin at Saniona’s headquarters in Boston, Massachusetts, who told us more about the potential plans.

Read the full interview with Rami Levin at biostock.se:

https://www.biostock.se/en/saniona-comments-on-the-possible-listing-in-the-usa/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Subscribe

Documents & Links

Quick facts

BioStock: Saniona comments on the possible listing in the USA
Tweet this

Quotes

We are in communication with the FDA on both the PWS and HO clinical programs, and we are also working with our team of clinical research organizations and contract manufacturers to prepare to initiate these studies. We look forward to starting the trials as expeditiously as possible
Rami Levin, CEO Saniona